First exosome-based liquid biopsy test receives FDA’s breakthrough device designation

June 19, 2019 Leave a comment

Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: U.S. Food and Drug Administration

First exosome-based liquid biopsy test receives FDA’s breakthrough device designation

Beckman research to boost astronaut fitness on NASA’s mission to Mars

MDimune announces a collaboration with Hanyang University on the projects selected through the 3rd BioDrone™ Award

Extracellular vesicles – the next generation in gene therapy delivery

$3.0m CRC-P grant to VivaZome Therapeutics and Partners for Customised Exosome Therapy

Cellular messengers improve cancer therapy

Single-cell transcriptomics reveal extracellular vesicles secretion with a cardiomyocyte proteostasis signature during pathological remodeling